Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation
The appropriate dosage of edaravone—a radioprotective agent—and its effect on tumors are unknown. This study evaluated the effects of edaravone on intestinal injuries and tumors in mice induced by whole body X-ray irradiation. Small intestinal mucositis was induced in C3H/HeNSlc mice using a single...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/45/7/340 |
_version_ | 1827733473875460096 |
---|---|
author | Terufumi Kawamoto Keisuke Sasai |
author_facet | Terufumi Kawamoto Keisuke Sasai |
author_sort | Terufumi Kawamoto |
collection | DOAJ |
description | The appropriate dosage of edaravone—a radioprotective agent—and its effect on tumors are unknown. This study evaluated the effects of edaravone on intestinal injuries and tumors in mice induced by whole body X-ray irradiation. Small intestinal mucositis was induced in C3H/HeNSlc mice using a single X-ray dose (15 Gy). Edaravone (15, 30, and 100 mg/kg) was administered 30 min before irradiation to evaluate its protective effect. After 3.5 days, the jejunum was removed and the histological changes were evaluated. Next, C3H/HeNSlc mice with squamous cell carcinoma VII tumors were provided the same single X-ray dose and 100 mg/kg edaravone; further, the tumors were immediately induced after irradiation. The tumor cell viability was detected using an in vivo–in vitro colony formation assay. We found that the intestinal colony-forming ability after irradiation was significantly higher in the 100 mg/kg edaravone group than that in the control group. Moreover, the apoptotic cells in the villi immunohistochemically stained with cleaved caspase-3 were significantly lower in the 100 mg/kg edaravone group than in the control group. We found no radioprotective effects of intraperitoneally inoculated edaravone in both hind legs on squamous cell carcinoma VII tumors. These findings suggest that 100 mg/kg edaravone exerts protective effects on small intestinal injuries without interfering with the antitumor effects of radiation. |
first_indexed | 2024-03-11T01:11:49Z |
format | Article |
id | doaj.art-90b1c6cb8d464d59995c62972a23cbde |
institution | Directory Open Access Journal |
issn | 1467-3037 1467-3045 |
language | English |
last_indexed | 2024-03-11T01:11:49Z |
publishDate | 2023-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Current Issues in Molecular Biology |
spelling | doaj.art-90b1c6cb8d464d59995c62972a23cbde2023-11-18T18:50:51ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452023-06-014575362537210.3390/cimb45070340Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of RadiationTerufumi Kawamoto0Keisuke Sasai1Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, JapanDepartment of Radiation Oncology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, JapanThe appropriate dosage of edaravone—a radioprotective agent—and its effect on tumors are unknown. This study evaluated the effects of edaravone on intestinal injuries and tumors in mice induced by whole body X-ray irradiation. Small intestinal mucositis was induced in C3H/HeNSlc mice using a single X-ray dose (15 Gy). Edaravone (15, 30, and 100 mg/kg) was administered 30 min before irradiation to evaluate its protective effect. After 3.5 days, the jejunum was removed and the histological changes were evaluated. Next, C3H/HeNSlc mice with squamous cell carcinoma VII tumors were provided the same single X-ray dose and 100 mg/kg edaravone; further, the tumors were immediately induced after irradiation. The tumor cell viability was detected using an in vivo–in vitro colony formation assay. We found that the intestinal colony-forming ability after irradiation was significantly higher in the 100 mg/kg edaravone group than that in the control group. Moreover, the apoptotic cells in the villi immunohistochemically stained with cleaved caspase-3 were significantly lower in the 100 mg/kg edaravone group than in the control group. We found no radioprotective effects of intraperitoneally inoculated edaravone in both hind legs on squamous cell carcinoma VII tumors. These findings suggest that 100 mg/kg edaravone exerts protective effects on small intestinal injuries without interfering with the antitumor effects of radiation.https://www.mdpi.com/1467-3045/45/7/340enteritisradiationradioprotectorradiotherapy |
spellingShingle | Terufumi Kawamoto Keisuke Sasai Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation Current Issues in Molecular Biology enteritis radiation radioprotector radiotherapy |
title | Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation |
title_full | Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation |
title_fullStr | Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation |
title_full_unstemmed | Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation |
title_short | Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation |
title_sort | edaravone exerts protective effects on mice intestinal injury without interfering with the anti tumor effects of radiation |
topic | enteritis radiation radioprotector radiotherapy |
url | https://www.mdpi.com/1467-3045/45/7/340 |
work_keys_str_mv | AT terufumikawamoto edaravoneexertsprotectiveeffectsonmiceintestinalinjurywithoutinterferingwiththeantitumoreffectsofradiation AT keisukesasai edaravoneexertsprotectiveeffectsonmiceintestinalinjurywithoutinterferingwiththeantitumoreffectsofradiation |